申请人:Ferro Therapeutics, Inc.
公开号:US20220227765A1
公开(公告)日:2022-07-21
This present disclosure relates to compounds with ferroptosis inducing activity, a method of treating a subject with cancer with the compounds, and combination treatments with a second therapeutic agent.